{"id":3653,"date":"2021-08-16T05:18:14","date_gmt":"2021-08-16T05:18:14","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=3653"},"modified":"2023-08-29T17:50:42","modified_gmt":"2023-08-29T17:50:42","slug":"invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=3653","title":{"rendered":"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229"},"content":{"rendered":"<p>\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002<\/p>\n<p>\u8fd9\u4e24\u9879\u7f8e\u56fd\u548c\u6b27\u6d32\u4e13\u5229\u90fd\u6db5\u76d6\u4e86Invex\u4f7f\u7528GLP-1\u53d7\u4f53\u6fc0\u52a8\u5242(\u5305\u62ecExenatide)\u964d\u4f4e\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u76f8\u5173ICP\u5347\u9ad8\u7684\u77e5\u8bc6\u4ea7\u6743\u3002<\/p>\n<p>Invex\u6267\u884c\u8463\u4e8bTom Duthy\u535a\u58eb\u8bf4:\u201c\u83b7\u5f97\u6b27\u6d32\u4e13\u5229\u662f\u6211\u4eec\u827e\u585e\u90a3\u80bd\u5728IIH\u548c\u53ef\u80fd\u4e0eICP\u5347\u9ad8\u76f8\u5173\u7684\u5176\u4ed6\u9002\u5e94\u75c7\u65b9\u9762\u7684\u6574\u4f53\u77e5\u8bc6\u4ea7\u6743\u6218\u7565\u7684\u91cd\u8981\u7ec4\u6210\u90e8\u5206\u3002\u201d<\/p>\n<p>\u201c\u8fd9\u4e2a\u4e13\u5229\u81f3\u5c11\u4f1a\u63d0\u4f9b\u4fdd\u62a4,\u76f4\u52302035\u5e748\u6708,\u5f53\u8003\u8651\u5728\u6211\u4eec\u7684\u6b27\u6d32\u5b64\u513f\u836f\u7269\u540d\u79f0,\u63d0\u4f9b10\u5e74\u7684\u5e02\u573a\u6392\u4ed6\u6027Exenatide\u6cbb\u7597\u9885\u5185\u9ad8\u538b\u75c7,\u6388\u4e88\u4e00\u4e2a\u5f3a\u5927\u7684\u6574\u4f53IP\u4f4d\u7f6eInvex\u5728\u6b27\u6d32,\u9664\u4e86\u4e00\u5957\u7c7b\u4f3c\u7684IP\u5728\u7f8e\u56fd\u4e3e\u884c,\u201cDuthy\u535a\u58eb\u8865\u5145\u8bf4\u3002<\/p>\n<h2>\u5546\u4e1a\u5316ICP\u6cbb\u7597<\/h2>\n<p>Invex\u4e13\u6ce8\u4e8e\u827e\u585e\u90a3\u80bd\u7684\u5546\u4e1a\u5316\uff0c\u5df2\u5c06\u5176\u91cd\u65b0\u7528\u9014\u5e76\u6ce8\u518c\u4e3aPresendin\uff0c\u7528\u4e8e\u6cbb\u7597IIH\u76f8\u5173\u7684ICP\u3002<\/p>\n<p>\u8be5\u836f\u662fGLP-1\u6fc0\u52a8\u5242exendin-4\u7684\u4e00\u4e2a\u5c0f\u80bd\u548c\u5408\u6210\u7248\u672c\uff0c\u81ea2005\u5e74\u548c2006\u5e74\u4ee5\u6765\uff0cexendin-4\u5206\u522b\u5728\u7f8e\u56fd\u548c\u6b27\u6d32\u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u75972\u578b\u7cd6\u5c3f\u75c5\u3002<\/p>\n<p>\u7814\u7a76\u8868\u660e\uff0cGLP-1\u53d7\u4f53\u5728\u5927\u8111\u8109\u7edc\u819c\u4e1b\u4e2d\u8868\u8fbe\uff0c\u827e\u585e\u90a3\u80bd\u53ef\u4e0e\u8fd9\u4e9b\u53d7\u4f53\u7ed3\u5408\uff0c\u51cf\u5c11\u8111\u810a\u6db2\u7684\u5206\u6ccc\u3002<\/p>\n<p>\u5728IIH\u4e2d\uff0c\u8111\u810a\u6db2\u79ef\u805a\u5e76\u589e\u52a0\u5927\u8111\u538b\u529b\uff0c\u5bfc\u81f4\u60a3\u8005\u51fa\u73b0\u8870\u5f31\u75c7\u72b6\uff0c\u5305\u62ec\u65e5\u5e38\u5934\u75db\u548c\u89c6\u529b\u969c\u788d\u3002<\/p>\n<p>\u5728\u8fc7\u53bb\u5341\u5e74\u91cc\uff0cIIH\u7684\u53d1\u75c5\u7387\u4e0a\u5347\u4e86350%\u4ee5\u4e0a\u3002<\/p>\n<p>\u57286\u6708\u4efd\u8fd9\u4e2a\u5b63\u5ea6\uff0c<a href=\"http:\/\/smallcaps-production.test\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/?lang=cn\">Invex\u7f29\u5c0f\u4e86\u5bf9\u53ef\u80fd\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u7ec4\u7ec7(CMOs)<\/a>\u7684\u641c\u7d22\u8303\u56f4\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u5df2\u7ecf\u8bc4\u4f30\u4e86\u8bb8\u591a\u4e13\u95e8\u7528\u4e8e\u4e34\u5e8a\u548c\u5546\u4e1a\u7528\u9014\u7684\u591a\u80bd\u914d\u65b9\u7684CMOs\u3002<\/p>\n<p>\u5728\u8fd9\u4e2a\u9636\u6bb5\uff0cInvex\u6b63\u5728\u5ba1\u67e5\u63d0\u6848\uff0c\u5e76\u7ee7\u7eed\u4e0e\u6f5c\u5728\u5236\u9020\u5546\u8fdb\u884c\u5408\u540c\u8c08\u5224\u3002\u8be5\u516c\u53f8\u8868\u793a\uff0c\u4e00\u65e6\u7b7e\u7f72\u5177\u6709\u7ea6\u675f\u529b\u7684\u534f\u8bae\uff0c\u5e02\u573a\u5c06\u8fdb\u884c\u66f4\u65b0\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002 \u8fd9\u4e24\u9879\u7f8e\u56fd\u548c\u6b27\u6d32\u4e13\u5229\u90fd\u6db5\u76d6\u4e86Invex\u4f7f\u7528GLP-1\u53d7\u4f53\u6fc0\u52a8\u5242(\u5305\u62ecExenatide)\u964d\u4f4e\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b(IIH)\u76f8\u5173ICP\u5347\u9ad8\u7684\u77e5\u8bc6\u4ea7\u6743\u3002 Invex\u6267\u884c\u8463\u4e8bTom Duthy\u535a\u58eb\u8bf4:\u201c\u83b7\u5f97\u6b27\u6d32\u4e13\u5229\u662f\u6211\u4eec\u827e\u585e\u90a3\u80bd\u5728IIH\u548c\u53ef\u80fd\u4e0eICP\u5347\u9ad8\u76f8\u5173\u7684\u5176\u4ed6\u9002\u5e94\u75c7\u65b9\u9762\u7684\u6574\u4f53\u77e5\u8bc6\u4ea7\u6743\u6218\u7565\u7684\u91cd\u8981\u7ec4\u6210\u90e8\u5206\u3002\u201d \u201c\u8fd9\u4e2a\u4e13\u5229\u81f3\u5c11\u4f1a\u63d0\u4f9b\u4fdd\u62a4,\u76f4\u52302035\u5e748\u6708,\u5f53\u8003\u8651\u5728\u6211\u4eec\u7684\u6b27\u6d32\u5b64\u513f\u836f\u7269\u540d\u79f0,\u63d0\u4f9b10\u5e74\u7684\u5e02\u573a\u6392\u4ed6\u6027Exenatide\u6cbb\u7597\u9885\u5185\u9ad8\u538b\u75c7,\u6388\u4e88\u4e00\u4e2a\u5f3a\u5927\u7684\u6574\u4f53IP\u4f4d\u7f6eInvex\u5728\u6b27\u6d32,\u9664\u4e86\u4e00\u5957\u7c7b\u4f3c\u7684IP\u5728\u7f8e\u56fd\u4e3e\u884c,\u201cDuthy\u535a\u58eb\u8865\u5145\u8bf4\u3002 \u5546\u4e1a\u5316ICP\u6cbb\u7597 Invex\u4e13\u6ce8\u4e8e\u827e\u585e\u90a3\u80bd\u7684\u5546\u4e1a\u5316\uff0c\u5df2\u5c06\u5176\u91cd\u65b0\u7528\u9014\u5e76\u6ce8\u518c\u4e3aPresendin\uff0c\u7528\u4e8e\u6cbb\u7597IIH\u76f8\u5173\u7684ICP\u3002 \u8be5\u836f\u662fGLP-1\u6fc0\u52a8\u5242exendin-4\u7684\u4e00\u4e2a\u5c0f\u80bd\u548c\u5408\u6210\u7248\u672c\uff0c\u81ea2005\u5e74\u548c2006\u5e74\u4ee5\u6765\uff0cexendin-4\u5206\u522b\u5728\u7f8e\u56fd\u548c\u6b27\u6d32\u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u75972\u578b\u7cd6\u5c3f\u75c5\u3002 \u7814\u7a76\u8868\u660e\uff0cGLP-1\u53d7\u4f53\u5728\u5927\u8111\u8109\u7edc\u819c\u4e1b\u4e2d\u8868\u8fbe\uff0c\u827e\u585e\u90a3\u80bd\u53ef\u4e0e\u8fd9\u4e9b\u53d7\u4f53\u7ed3\u5408\uff0c\u51cf\u5c11\u8111\u810a\u6db2\u7684\u5206\u6ccc\u3002 \u5728IIH\u4e2d\uff0c\u8111\u810a\u6db2\u79ef\u805a\u5e76\u589e\u52a0\u5927\u8111\u538b\u529b\uff0c\u5bfc\u81f4\u60a3\u8005\u51fa\u73b0\u8870\u5f31\u75c7\u72b6\uff0c\u5305\u62ec\u65e5\u5e38\u5934\u75db\u548c\u89c6\u529b\u969c\u788d\u3002 \u5728\u8fc7\u53bb\u5341\u5e74\u91cc\uff0cIIH\u7684\u53d1\u75c5\u7387\u4e0a\u5347\u4e86350%\u4ee5\u4e0a\u3002 \u57286\u6708\u4efd\u8fd9\u4e2a\u5b63\u5ea6\uff0cInvex\u7f29\u5c0f\u4e86\u5bf9\u53ef\u80fd\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u7ec4\u7ec7(CMOs)\u7684\u641c\u7d22\u8303\u56f4\u3002 \u8be5\u516c\u53f8\u5df2\u7ecf\u8bc4\u4f30\u4e86\u8bb8\u591a\u4e13\u95e8\u7528\u4e8e\u4e34\u5e8a\u548c\u5546\u4e1a\u7528\u9014\u7684\u591a\u80bd\u914d\u65b9\u7684CMOs\u3002 \u5728\u8fd9\u4e2a\u9636\u6bb5\uff0cInvex\u6b63\u5728\u5ba1\u67e5\u63d0\u6848\uff0c\u5e76\u7ee7\u7eed\u4e0e\u6f5c\u5728\u5236\u9020\u5546\u8fdb\u884c\u5408\u540c\u8c08\u5224\u3002\u8be5\u516c\u53f8\u8868\u793a\uff0c\u4e00\u65e6\u7b7e\u7f72\u5177\u6709\u7ea6\u675f\u529b\u7684\u534f\u8bae\uff0c\u5e02\u573a\u5c06\u8fdb\u884c\u66f4\u65b0\u3002<\/p>\n","protected":false},"author":3,"featured_media":235,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[273],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229<\/title>\n<meta name=\"description\" content=\"\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229\" \/>\n<meta property=\"og:description\" content=\"\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-16T05:18:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:50:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Lithium-Australia-LieNA-patent-extraction-technology-ASX-LIT-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229\" \/>\n<meta name=\"twitter:description\" content=\"\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/\",\"name\":\"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-08-16T05:18:14+00:00\",\"dateModified\":\"2023-08-29T17:50:42+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229","description":"\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229","og_description":"\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/","og_site_name":"smallcapsCN","article_published_time":"2021-08-16T05:18:14+00:00","article_modified_time":"2023-08-29T17:50:42+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Lithium-Australia-LieNA-patent-extraction-technology-ASX-LIT-1.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229","twitter_description":"\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/","url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/","name":"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-08-16T05:18:14+00:00","dateModified":"2023-08-29T17:50:42+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u8fd1\u65e5\uff0cInvex Therapeutics (ASX: IXC)\u83b7\u5f97\u4e86\u5176\u63d0\u9ad8\u9885\u5185\u538b(ICP)\u6cbb\u7597\u836f\u7269\u57c3\u585e\u90a3\u80bd(Exenatide)\u7684\u6b27\u6d32\u4e13\u5229\uff0c\u4fdd\u62a4\u4e86\u8be5\u4e13\u5229\u5728\u8be5\u5730\u533a\u548c\u7f8e\u56fd\u7684\u77e5\u8bc6\u4ea7\u6743\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-european-patent-elevated-intracranial-pressure-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Invex Therapeutics\u83b7\u5f97\u6b27\u6d32\u9885\u5185\u538b\u5347\u9ad8\u6cbb\u7597\u4e13\u5229"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3653"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3653"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3653\/revisions"}],"predecessor-version":[{"id":12798,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3653\/revisions\/12798"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/235"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}